PH23867A - Method of treating parkinson's disease using indolone derivatives - Google Patents

Method of treating parkinson's disease using indolone derivatives

Info

Publication number
PH23867A
PH23867A PH36934A PH36934A PH23867A PH 23867 A PH23867 A PH 23867A PH 36934 A PH36934 A PH 36934A PH 36934 A PH36934 A PH 36934A PH 23867 A PH23867 A PH 23867A
Authority
PH
Philippines
Prior art keywords
disease
treating parkinson
indolone derivatives
hydrogen
4alkyl
Prior art date
Application number
PH36934A
Other languages
English (en)
Inventor
David Andrew Arlwydd Owen
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10617727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH23867(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PH23867A publication Critical patent/PH23867A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PH36934A 1987-05-21 1988-05-16 Method of treating parkinson's disease using indolone derivatives PH23867A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712073A GB8712073D0 (en) 1987-05-21 1987-05-21 Medicament

Publications (1)

Publication Number Publication Date
PH23867A true PH23867A (en) 1989-11-23

Family

ID=10617727

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36934A PH23867A (en) 1987-05-21 1988-05-16 Method of treating parkinson's disease using indolone derivatives

Country Status (21)

Country Link
US (2) US4824860A (da)
EP (1) EP0299602B1 (da)
JP (1) JPH062672B2 (da)
AT (1) ATE83659T1 (da)
AU (1) AU599792B2 (da)
CA (1) CA1305421C (da)
DE (1) DE3876877T2 (da)
DK (1) DK169609B1 (da)
ES (1) ES2052717T3 (da)
GB (1) GB8712073D0 (da)
GR (1) GR3007251T3 (da)
HK (1) HK1000913A1 (da)
HU (1) HU201871B (da)
IE (1) IE63511B1 (da)
LU (1) LU90098I2 (da)
MX (1) MX9203543A (da)
NL (1) NL970006I2 (da)
NZ (1) NZ224709A (da)
PH (1) PH23867A (da)
PT (1) PT87542B (da)
ZA (1) ZA883602B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
AU4312593A (en) * 1992-05-18 1993-12-13 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
GB9511366D0 (en) * 1995-06-06 1995-08-02 Smithkline Beecham Plc Novel formulations
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9612752D0 (en) * 1996-06-19 1996-08-21 Smithkline Beecham Plc Novel treatment
JP2000516959A (ja) * 1996-08-27 2000-12-19 アメリカン・ホーム・プロダクツ・コーポレイション ４―アミノエトキシインドロン誘導体
AU3555099A (en) * 1998-04-13 1999-11-01 American Home Products Corporation 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
US6176242B1 (en) 1999-04-30 2001-01-23 Medtronic Inc Method of treating manic depression by brain infusion
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
US6871098B2 (en) * 2000-10-30 2005-03-22 Medtronic, Inc. Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
PT1545546E (pt) * 2002-09-13 2007-07-02 Motac Neuroscience Ltd Tratamento da discinesia com 2, 3-benzodiazepinas
EP1539135B1 (en) * 2002-09-17 2007-04-25 Motac Neuroscience Limited Treatment of dyskinesia
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
US20050250803A1 (en) * 2003-11-26 2005-11-10 Pfizer Inc Combination of dopamine agonists and monoamine reuptake inhibitors
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US20090325911A1 (en) * 2005-10-21 2009-12-31 Caritas St. Elizabeth Medical Center Of Boston, Inc. Use of Androgens for the Treatment of Parkinson's Disease
AU2007235232B2 (en) * 2006-04-06 2013-07-11 Nupathe Inc. Implants for the treatment of dopamine associated states
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
CN101574341B (zh) * 2008-05-05 2012-12-19 北京德众万全医药科技有限公司 一种罗匹尼罗的口服固体药物组合物
US20110195117A1 (en) * 2008-09-01 2011-08-11 Lupin Limited Controlled release compositions of ropinirole
EP2346494A2 (en) 2008-09-29 2011-07-27 Wockhardt Limited Extended release dosage form of ropinirole
WO2010044108A2 (en) 2008-10-17 2010-04-22 Rubicon Research Private Limited Controlled release formulations of ropinirole
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
EP2563347B1 (en) 2010-04-30 2016-10-12 Teikoku Pharma USA, Inc. Propynylaminoindan transdermal compositions
KR101853082B1 (ko) 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
EP2776020B1 (en) 2011-11-09 2019-09-11 Teikoku Seiyaku Co., Ltd. Methods for the treatment of skin neoplasms
NZ706590A (en) 2012-11-02 2016-02-26 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
WO2015168616A1 (en) * 2014-05-02 2015-11-05 Abbvie Inc. Neuronal nicotinic agonists and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4588740A (en) * 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones

Also Published As

Publication number Publication date
ZA883602B (en) 1989-04-26
DK275488A (da) 1988-11-22
EP0299602B1 (en) 1992-12-23
NL970006I2 (nl) 1997-10-01
PT87542B (pt) 1992-09-30
GR3007251T3 (da) 1993-07-30
EP0299602A3 (en) 1990-06-06
HK1000913A1 (en) 1998-05-08
MX9203543A (es) 1992-07-01
CA1305421C (en) 1992-07-21
HU201871B (en) 1991-01-28
ATE83659T1 (de) 1993-01-15
DE3876877D1 (de) 1993-02-04
JPH062672B2 (ja) 1994-01-12
PT87542A (pt) 1989-05-31
NL970006I1 (nl) 1997-04-01
GB8712073D0 (en) 1987-06-24
EP0299602A2 (en) 1989-01-18
AU599792B2 (en) 1990-07-26
US4912126A (en) 1990-03-27
IE881469L (en) 1988-11-21
DE3876877T2 (de) 1993-04-29
DK169609B1 (da) 1994-12-27
NZ224709A (en) 1997-02-24
JPS63303966A (ja) 1988-12-12
ES2052717T3 (es) 1994-07-16
LU90098I2 (fr) 1997-09-25
AU1644588A (en) 1988-11-24
HUT47217A (en) 1989-02-28
DK275488D0 (da) 1988-05-19
IE63511B1 (en) 1995-05-03
US4824860A (en) 1989-04-25

Similar Documents

Publication Publication Date Title
PH23867A (en) Method of treating parkinson's disease using indolone derivatives
EP0206497A3 (en) Process for the preparation of therapeutic nucleosides
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
LTIP919A (en) Drugs and process for preparing thereof
ATE178793T1 (de) L-dopa ester-enthaltende zusammensetzung
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
IL106785A0 (en) Use of nadh and nadph as drugs for treating alzheimer's disease
EP1006793A4 (en) COMPOSITIONS FOR TREATING ARRHYTHMIA AND METHODS OF TREATMENT
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
ES8707738A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihidroorotil-histidil-prolinamida
GB8608893D0 (en) D-nor-7-ergoline derivatives
HK127294A (en) Use of 2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo [4,5-d] azepin for the preparation of a medicament for the treatment of Parkinson's disease, or of Parkinsonism
EP0202986A3 (en) Use of "naftidrofuryl" in the treatment of neuropathies
EP0207514A3 (en) 1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use
OA09790A (en) "Paromomycin or its derivatives or salts thereof for parenteral treatment of human parasitic diseases".
SG114394G (en) Use of 2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepin for the preparation of a medicament for the treatment of Parkinson's disease or of parkinsonism